Certara (CERT) reported Q1 adjusted earnings Monday of $0.14 per diluted share, up from $0.10 a year earlier.
Analysts polled by FactSet expected $0.11.
Revenue for the quarter ended March 31 was $106 million, up from $96.7 million a year earlier.
Analysts surveyed by FactSet expected $105.1 million.
For 2025, the drug development software company reiterated its previous guidance of adjusted diluted EPS of $0.42 to $0.46 on revenue of $415 million to $425 million.
Analysts polled by FactSet expect non-GAAP EPS of $0.45 on revenue of $421.1 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。